These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 31608492

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Sprifermin (rhFGF18) enables proliferation of chondrocytes producing a hyaline cartilage matrix.
    Gigout A, Guehring H, Froemel D, Meurer A, Ladel C, Reker D, Bay-Jensen AC, Karsdal MA, Lindemann S.
    Osteoarthritis Cartilage; 2017 Nov; 25(11):1858-1867. PubMed ID: 28823647
    [Abstract] [Full Text] [Related]

  • 3. Sprifermin (rhFGF18) modulates extracellular matrix turnover in cartilage explants ex vivo.
    Reker D, Kjelgaard-Petersen CF, Siebuhr AS, Michaelis M, Gigout A, Karsdal MA, Ladel C, Bay-Jensen AC.
    J Transl Med; 2017 Dec 12; 15(1):250. PubMed ID: 29233174
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Striking a new path in reducing cartilage breakdown: combination of antioxidative therapy and chondroanabolic stimulation after blunt cartilage trauma.
    Riegger J, Joos H, Palm HG, Friemert B, Reichel H, Ignatius A, Brenner RE.
    J Cell Mol Med; 2018 Jan 12; 22(1):77-88. PubMed ID: 28834244
    [Abstract] [Full Text] [Related]

  • 8. Recombinant human FGF18 preserves depth-dependent mechanical inhomogeneity in articular cartilage.
    Meloni GR, Farran A, Mohanraj B, Guehring H, Cocca R, Rabut E, Mauck RL, Dodge GR.
    Eur Cell Mater; 2019 Aug 08; 38():23-34. PubMed ID: 31393594
    [Abstract] [Full Text] [Related]

  • 9. The combination of insulin-like growth factor 1 and osteogenic protein 1 promotes increased survival of and matrix synthesis by normal and osteoarthritic human articular chondrocytes.
    Loeser RF, Pacione CA, Chubinskaya S.
    Arthritis Rheum; 2003 Aug 08; 48(8):2188-96. PubMed ID: 12905472
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Expansion of human articular chondrocytes and formation of tissue-engineered cartilage: a step towards exploring a potential use of matrix-induced cell therapy.
    Munirah S, Samsudin OC, Aminuddin BS, Ruszymah BH.
    Tissue Cell; 2010 Oct 08; 42(5):282-92. PubMed ID: 20810142
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Responsiveness of bovine chondrocytes to growth factors in medium with different serum concentrations.
    van Susante JL, Buma P, van Beuningen HM, van den Berg WB, Veth RP.
    J Orthop Res; 2000 Jan 08; 18(1):68-77. PubMed ID: 10716281
    [Abstract] [Full Text] [Related]

  • 20. Immortalized mouse articular cartilage cell lines retain chondrocyte phenotype and respond to both anabolic factor BMP-2 and pro-inflammatory factor IL-1.
    Majumdar MK, Chockalingam PS, Bhat RA, Sheldon R, Keohan C, Blanchet T, Glasson S, Morris EA.
    J Cell Physiol; 2008 Apr 08; 215(1):68-76. PubMed ID: 17960567
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.